Kolumne, ORE

Original-Research: EV Digital Invest AG - from NuWays AG Classification of NuWays AG to EV Digital Invest AG Company Name: EV Digital Invest AG ISIN: DE000A3DD6W5 Reason for the research: Update Recommendation: Kaufen from: 28.05.2024 Target price: EUR 3.60 Target price on sight of: 12 Monaten Last rating change: Analyst: Frederik Jarchow Strategic partnership to unlock renewable energy projects Topic: EVDI announced to have entered a strategic partnership with Green FOX Energy - a project developer and owner of renewable energy plants.

28.05.2024 - 09:01:33

Original-Research: EV Digital Invest AG (von NuWays AG): Kaufen


Original-Research: EV Digital Invest AG - from NuWays AG

Classification of NuWays AG to EV Digital Invest AG

Company Name: EV Digital Invest AG
ISIN: DE000A3DD6W5

Reason for the research: Update
Recommendation: Kaufen
from: 28.05.2024
Target price: EUR 3.60
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Frederik Jarchow

Strategic partnership to unlock renewable energy projects
 
Topic: EVDI announced to have entered a strategic partnership with Green
FOX Energy - a project developer and owner of renewable energy plants. The
cooperation enables EVDI to offer direct investments into renewable energy
projects to its customers via its platform. In detail:
 
With this cooperation, EVDI is further expanding its product range of
"Engel & Völkers Digital Invest" that is currently comprising real-estate
investments into residential, office and logistics. The added green
investment opportunities not only give investors the opportunity to
diversify their investments even more broadly, but also to directly
participate from the transformation of the energy infrastructure. The
offered projects should allow low minimum investments of EUR 100 and rather
short terms of only 12 months.
 
In our view, the partnership should bode well for EVDI as 1) renewable
energy is one of the current megatrends showing a steep growth trajectory,
2) it should further diversify the business by reducing the dependency from
the developments in the real-estate sector and 3) it should attract new
target investor groups. Even better, operational EVDI can build on its
established two-stage review process (internal and external analysis by
renowned experts) used for real-estate projects. As a result, the first
solar project ("Solarpark Eyendorf") is already available on the platform.
 
Going forward, we expect more renewable projects to follow as Green FOX
EnergyŽs project pipeline is well filled with around 2GW peak and the
demand for electricity generation from renewable energy sources is expected
to increase by more than 60% until 2026 (according to the IEA).
 
In light of the promising strategic partnership with Green FOX Energy,
paired with first signs of revitalization of the real-estate market mainly
stemming from the anticipated reduction of interest rates, EVDI should
easily achieve its conservative guidance of EUR 4.9-5.8m in op. income (vs
eNuW: EUR 5.6m) and up to EUR -1.9m EBITDA, (eNuW: EUR -2m). While we see the
growth potential arising from the partnership, we play it safe, leaving our
estimates unchanged for now.
 
BUY on valuation with an unchanged PT of EUR 3.60, based on DCF.

You can download the research here:
http://www.more-ir.de/d/29921.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: Brockhaus Technologies AG (von Montega AG): Kaufen Original-Research: Brockhaus Technologies AG - von Montega AG Einstufung von Montega AG zu Brockhaus Technologies AG Unternehmen: Brockhaus Technologies AG ISIN: DE000A2GSU42 Anlass der Studie: Update Empfehlung: Kaufen seit: 13.06.2024 Kursziel: 71,00 EUR Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Christoph Hoffmann Roadshow-Feedback: Zweistelliges Gewinnwachstum erwartet Am gestrigen Dienstag waren wir mit dem CEO Marco Brockhaus, dem M&A-Verantwortlichen Paul Göhring sowie dem Head of Capital Markets Florian Peter auf Roadshow. (Boerse, 13.06.2024 - 15:51) weiterlesen...

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy Original-Research: Formycon AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Formycon AG Company Name: Formycon AG ISIN: DE000A1EWVY8 Reason for the research: Update Recommendation: Buy from: 13.06.2024 Target price: EUR80,00 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes, CFA First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000A1EWVY8). (Boerse, 13.06.2024 - 10:41) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Q1 & 2023 Ergebnisse Recommendation: Kaufen from: 12.06.2024 Target price: EUR113 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 12.06.2024 - 14:46) weiterlesen...

Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy Original-Research: Vidac Pharma Holding Plc - from Sphene Capital GmbH Classification of Sphene Capital GmbH to Vidac Pharma Holding Plc Company Name: Vidac Pharma Holding Plc ISIN: GB00BM9XQ619 Reason for the research: Initiation of Coverage Recommendation: Buy from: 12.06.2024 Target price: EUR 4.90 Target price on sight of: 36 months Last rating change: - Analyst: Peter Thilo Hasler Reversal of the abnormal metabolism of cancer cells We initiate research coverage of the shares of Vidac Pharma Holding plc with a Buy rating and a price target of EUR 4.90 (base case scenario). (Boerse, 12.06.2024 - 14:36) weiterlesen...

Original-Research: Koenig & Bauer AG (von Montega AG): Kaufen Original-Research: Koenig & Bauer AG - von Montega AG Einstufung von Montega AG zu Koenig & Bauer AG Unternehmen: Koenig & Bauer AG ISIN: DE0007193500 Anlass der Studie: Update Empfehlung: Kaufen seit: 12.06.2024 Kursziel: 17,00 EUR (zuvor: 16,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Patrick Speck (CESGA) Super drupa - Weltleitmesse bringt erhofften Auftragsschub Koenig & Bauer hat am Montag nach Börsenschluss über einen starken Auftragseingang infolge der jüngst zu Ende gegangenen Weltleitmesse drupa berichtet. (Boerse, 12.06.2024 - 10:31) weiterlesen...

Original-Research: ÖKOWORLD AG (von BankM AG): Kaufen Original-Research: ÖKOWORLD AG - von BankM AG Einstufung von BankM AG zu ÖKOWORLD AG Unternehmen: ÖKOWORLD AG ISIN: DE0005408686 Anlass der Studie: GB 2023, Basisstudien-Update Empfehlung: Kaufen seit: 11.06.2024 Kursziel: EUR 52,52 Kursziel auf Sicht von: 12 Monate Letzte Ratingänderung: Keine Analyst: Daniel Großjohann und Dr. (Boerse, 11.06.2024 - 14:56) weiterlesen...